Dyskinesia Pipeline for Drug Profile and Companies in H1 2017 Report


Posted May 30, 2017 by justinebiel

The pipeline guide evaluates Dyskinesia (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

 
ReportsnReports.com adds global Dyskinesia therapeutics pipeline market research report spread across, profiling 80 companies. In Depth Research on Dyskinesia therapeutics pipeline market H1 2017. The report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Main key players of H1 Dyskinesia Pipeline are Adamas Pharmaceuticals Inc,Addex Therapeutics Ltd, Advicenne SA, Astraea Therapeutics LLC, Avanir Pharmaceuticals Inc,Bionomics Ltd, Catalyst Biosciences Inc, Catalyst Pharmaceuticals Inc, Cavion LLC, Clevexel Pharma SAS, EpiVax Inc,Heptares Therapeutics Ltd,Ipsen SA 34,Merz Pharma GmbH & Co KgaA,Neurim Pharmaceuticals LtD,Neurocrine Biosciences Inc,Neurolixis Inc, Osmotica Pharmaceutical Corp,Phenomenome Discoveries Inc, Sage Therapeutics Inc, SciFluor Life Sciences LLC, SOM Biotech SL, Synchroneuron Inc, Teva Pharmaceutical Industries Ltd.

Dyskinesia Pipeline Market Review, H1 2017, provides comprehensive information on the therapeutics under development for Dyskinesia (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Dyskinesia - Drug Profiles : (dextromethorphan + quinidine sulfate), A-2M13677, abobotulinumtoxinA, acamprosate calcium SR, amantadine hydrochloride ER, amantadine hydrochloride ER, AT-127, AT-326, AT-403, befiradol, brexanolone, CPP-115, CVXL-0107, CX-8998, cycloserine, deutetrabenazine more..

Discount Available at http://www.reportsnreports.com/contacts/discount.aspx?name=1010747 (This report is available at upto 25% Discount till June 02nd 2017.)

The Dyskinesia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dyskinesia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 1, 2, 24, 11, 1, 72, 21 and 2 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 42 and 7 molecules, respectively.

Order a copy of this research report at http://www.reportsnreports.com/purchase.aspx?name=1010747

Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Dyskinesia (Central Nervous System). The pipeline guide reviews pipeline therapeutics for Dyskinesia (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. The pipeline guide reviews key companies involved in Dyskinesia (Central Nervous System) therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Dyskinesia (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. The pipeline guide reviews latest news related to pipeline therapeutics for Dyskinesia (Central Nervous System).

Dyskinesia (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Inquiry of this report http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1010747

About Us:
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details at [email protected] and we would be happy to help you find the business intelligence that you need. ReportsnReports.com offers research studies on agriculture, energy and power, automotive, Semiconductor and Electronics, Manufacturing & Construction, chemicals, environment, medical devices, healthcare, food and beverages, water and much more.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By justinebiel
Country India
Categories Health , Industry , News
Tags dyskinesia , dyskinesia market , dyskinesia pipeline , dyskinesia report
Last Updated May 30, 2017